therapy, a selective serotonin reuptake inhibitor, on the mood and physical function in
FMS patients.
Forty female FMS patients were included in this study. They were classified random
ly into two groups. The first group was 20 patients assigned to an exercise program and
the second group was also 20 patients received fluoxetine (20mg/day). Subjects were
tested at entry and at 20 weeks. Tests included the beck depression inventory (BDI), state
trait anxiety inventory (STA1), health assessment questionnaire (HAQ), six minute walk
test, fibromyalgia impact questionnaire (FIQ), and a measure of tender points, knee
strength, and serum serotonin level.
Our results showed that all variables measuring physical function and mood im
proved significantly in both groups, exercised led to significantly more improvement in
all variables measuring physical function and mood.
In conclusion, this study supports the role of exercise rehabilitation in the manage
ment of FMS. |
